Hepatitis B virus (HBV) is a main cause of chronic liver disease worldwide and can lead to
severe liver diseases. The World Health Organization has planned to eliminate viral …

Perinatal or mother‐to‐child transmission (MTCT) of hepatitis B virus (HBV) remains the
major risk factor for chronic HBV infection worldwide. In addition to hepatitis B immune …

Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) remains high even with the
proper use of active-passive immunoprophylaxis in newborns. Mothers with significant …

In areas where hepatitis B virus (HBV) is endemic, mother-to-child transmission (MTCT) is
the major route of infection of children. Blocking MTCT of HBV therefore would reduce its …

There are no standard guidelines to follow when a patient with chronic hepatitis B infection
becomes pregnant or desires pregnancy. Topics to consider include which patients to treat …

Objective. To describe the antiviral treatment patterns for chronic hepatitis B (CHB) among
pregnant and nonpregnant women. Methods. Using 2011 MarketScan claims, we calculated …

Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) is the primary cause of
chronic HBV infection worldwide. MTCT prevention and antiviral treatment of infected …

Chronic hepatitis B virus (HBV) remains a leading cause of cirrhosis and hepatocellular
carcinoma worldwide. Because chronic hepatitis B infection is rarely eradicated, preventing …

BACKGROUND: Women who are taking antiviral agents and become pregnant have several
options that include, continuing therapy, ceasing drugs, or switching to safer drugs …

Chronic HBV infection is estimated to affect> 350 million people worldwide and represents a
substantial source of morbidity and mortality related to cirrhosis and hepatocellular …